Bcr-abl and v-abl mediated inhibition of apoptosis is independent of NF-κB activation.

被引：0
|
作者：
Munzert, GM [1 ]
Kirchner, D [1 ]
Stobbe, H [1 ]
Bergmann, L [1 ]
机构：
[1] Univ Ulm, Ulm, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
450
引用
收藏
页码：103A / 103A
页数：1
相关论文
共 50 条
  • [41] IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1
    Hsieh, Mo-Ying
    Van Etten, Richard A.
    BLOOD, 2014, 123 (15) : 2401 - 2411
  • [42] NF-κB suppresses ROS levels in BCR-ABL+ cells to prevent activation of JNK and cell death
    Stein, S. J.
    Baldwin, A. S.
    ONCOGENE, 2011, 30 (45) : 4557 - 4566
  • [43] NF-κB suppresses ROS levels in BCR–ABL+ cells to prevent activation of JNK and cell death
    S J Stein
    A S Baldwin
    Oncogene, 2011, 30 : 4557 - 4566
  • [44] Protein kinase D2 mediates activation of nuclear factor κB by Bcr-Abl in Bcr-Abl+ human myeloid leukemia cells
    Mihailovic, T
    Marx, M
    Auer, A
    Van Lint, J
    Schmid, M
    Weber, C
    Seufferlein, T
    CANCER RESEARCH, 2004, 64 (24) : 8939 - 8944
  • [45] Novel anti-Bcr-Abl strategy consisting of arsenic trioxide and CGP57148B lowers Bcr-Abl levels and tyrosine kinase activity resulting in apoptosis and differentiation of Bcr-Abl positive human leukemia cells.
    Perkins, C
    Fang, GF
    Orlando, M
    Porosnicu, M
    Kim, C
    Whittmann, S
    Wen, JH
    Bhalla, K
    BLOOD, 1999, 94 (10) : 592A - 593A
  • [46] Proton Pump Inhibitors Augment Nilotinib and Dasatinib Mediated Bcr-Abl Kinase Inhibition.
    Hiwase, Devendra K.
    Eadie, Laura
    Saunders, Verity
    Hughes, Timothy
    White, Deborah L.
    BLOOD, 2010, 116 (21) : 1626 - 1627
  • [47] Expression of BCR-ABL does not inhibit apoptosis in vitro, on a B lymphoblastoid cell line.
    Castro, FA
    Brumatti, G
    Amarante-Mendes, GP
    BLOOD, 2004, 104 (11) : 146B - 146B
  • [48] Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis
    Shah, Neil P.
    Kasap, Corynn
    Weier, Christopher
    Balbas, Minna
    Nicoll, John M.
    Bleickardt, Eric
    Nicaise, Claude
    Sawyers, Charles L.
    CANCER CELL, 2008, 14 (06) : 485 - 493
  • [49] Bcr-Abl independent activation of Erk1/2 in an imatinib resistant cell line.
    da Silva, Danielle Cardoso
    Moreira, Miguel A.
    Maia, Raquel C.
    Vasconcelos, Flavia C.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 50 - 50
  • [50] Differentiation occurs during v-Abl mediated transformation of pre-pro B cells
    Gunthart, Mirja
    Rosenberg, Naomi
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S320 - S320
12345